TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis

Kidney International

Volumn 71, Issue 9, 2007, Pages 882-888

  Song, C Y ^a   Kim, B C ^a   Hong, H K ^a   Lee, H S ^a  

^a Seoul National University   (South Korea)

Author keywords

2(I) collagen; Anti GBM glomerulonephritis; ERK activity; PAI 1; TGF signaling

Indexed keywords

COLLAGEN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN SUBUNIT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRESCENTIC GLOMERULONEPHRITIS; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HETEROZYGOTE; HYPOTHESIS; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; BLOOD UREA NITROGEN; CAPILLARIES; COLLAGEN TYPE I; CREATININE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS; KIDNEY; KIDNEY CORTEX; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINURIA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RENAL CIRCULATION; RNA, MESSENGER;

EID: 34247478597     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002149     Document Type: Article

References (44)

1. Coimbra T, Wiggins R, Noh JW et al. Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991; 138: 223-234.
2. Franzen P, ten Dijke P, Ichijo H et al. Cloning of a TGF-βtype I receptor that forms a heteromeric complex with TGF-β type II receptor. Cell 1994; 75: 681-692.
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000; 342: 1350-1358.
4. Dennler S, Itoh S, Vivien D et al. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promotor of human plasminogen activator inhibitor-type I gene. EMBO J 1998; 17: 3091-3100.
5. Rondeau E, Mougenot B, Lacave R et al. Plasminogen activator inhibitor I in renal fibrin deposits of human nephropathies. Clin Nephrol 1990; 33: 55-60.
6. Lee HS, Park SY, Moon KC et al. mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis. Histopathology 2001; 39: 203-209.
7. Malliaros J, Holdsworth SR, Wojta J et al. Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int 1993; 44: 557-564.
8. Feng L, Tang WW, Loskutoff DJ, Wilson CB. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 1993; 3: 1753-1764.
9. Lloyd CM, Minto AW, Dorf ME et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371-1380.
10. Bokemeyer D, Guglielmi KE, McGinty A et al. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997; 100: 582-588.
11. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-735.
12. Huwiler A, Pfeilschifter J. Transforming growth factor-β2 stimulates acute and chronic activation of mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 1994; 354: 255-256.
13. Hayashida T, Poncelet A-C, Hubchak SC, Schnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 1999; 56: 1710-1720.
14. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 2003; 17: 1576-1578.
15. Guo B, Inoki K, Isono M et al. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-β in rat mesangial cells. Kidney Int 2005; 68: 972-984.
16. de Caestecker MP, Parks WT, Frank CJ et al. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 1998; 12: 1587-1592.
17. Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev 1999; 13: 804-816.
18. Funaba M, Zimmerman CM, Mathews LS. Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002; 277: 41361-41368.
19. Zhou A, Ueno H, Shimomura M et al. Blockade of TGF-β action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. Kidney Int 2003; 64: 92-101.
20. Kanamaru Y, Nakao A, Mamura M et al. Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 2001; 166: 2818-2823.
21. Oshima M, Oshima H, Taketo MM. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996; 179: 297-302.
22. Drew AF, Tucker HL, Liu H et al. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol 2001; 281: F1157-F1163.
23. Selvey S, Thompson EW, Matthaei K et al. β-actin - an unsuitable internal control for RT-PCR. Mol Cell Probes 2001; 15: 307-311.
24. -ΔΔCT method. Methods 2001; 25: 402-408.
25. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996; 49: 1187-1198.
26. Masaki T, Stambe C, Hill PA et al. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol 2004; 15: 1835-1843.
27. Ohashi R, Nakagawa T, Watanabe S et al. Inhibition of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway. Am J Pathol 2004; 164: 477-485.
28. Tang WW, Feng L, Loskutoff DJ, Wilson CB. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 2000; 84: 40-48.
29. Hong HK, Song CY, Kim BC, Lee HS. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells. Translat Res 2006; 148: 171-179.
30. Poncelet A-C, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001; 276: 6983-6992.
31. Goumenos D, Tsomi K, Iatrou C et al. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 1998; 13: 1652-1661.
32. Kim HW, Kim BC, Song CY et al. Heterozygous mice for TGF-βIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy. Kidney Int 2004; 66: 1859-1865.
33. Xu Z-G, Lanting L, Vaziri ND et al. Upregulation of angiotensin II type I receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney. Circulation 2005; 111: 1962-1969.
34. Yue J, Mulder KM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-β. Methods Mol Biol 2000; 142: 125-131.
35. Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371-374.
36. Akagi Y, Isaka Y, Arai M et al. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996; 50: 148-155.
37. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.
38. Grygielko ET, Martin WM, Tweed C et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 2005; 313: 651-943.
39. Im Y-H, Kim HT, Kim IY et al. Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res 2001; 61: 6665-6668.
40. Salant DJ, Cybulsky AV. Experimental glomerulonephritis. Methods Enzymol 1988; 162: 421-461.
41. Lee HS, Kim TS. A morphometric study of preeclamptic nephropathy with focal segmental glomerulosclerosis. Clin Nephrol 1995; 44: 14-21.
42. Lee HS, Kim BC, Kim YS et al. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 1996; 50: 1582-1590.
43. Marino JH, Cook P, Miller KS. Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J Immunol Methods 2003; 283: 291-306.
44. Schmid H, Cohen CD, Henger A et al. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int 2003; 64: 356-360.